NCT05526248 2026-03-11
ARAMON
Bayer
Phase 2 Completed
Clinical Trials
6 trialsNCT04736199 2026-02-27
ARANOTE
Bayer
Phase 3 Completed
NCT02200614 2022-06-28
ARAMIS
Bayer
Phase 3 Completed
NCT03004534 2020-04-03
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Translational Research in Oncology
Phase EARLY_PHASE1 Completed
NCT01317641 2017-03-29
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
Orion Corporation, Orion Pharma
Phase 1/2 Completed
NCT01429064 2017-02-20
Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001
Orion Corporation, Orion Pharma
Phase 2 Completed